The nuclear localization of GSK3β has been related to a mesenchymal phenotype in triple negative breast cancer and pancreatic cancer, and the increase in its expression with poor prognosis in urothelial carcinoma renal, pancreatic, leukemia and triple negative breast cancer38. Here, GSK3B is linked to triple-negative breast carcinoma.